Craft

iRhythm

Stock Price

$91.5

2024-05-21

Market Capitalization

$2.8 B

2024-05-21

Revenue

$492.7 M

FY, 2023

iRhythm Summary

Company Summary

Overview
iRhythm is a digital healthcare company that develops a solution to diagnose cardiac arrhythmias. Its platform include Zio, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with cloud-based data analytics to help physicians monitor patients and diagnose arrhythmias.
Type
Public
Status
Active
Founded
2006
HQ
San Francisco, CA, US | view all locations
Website
http://www.irhythmtech.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Mark Day

    Mark Day, Chief Technology Officer

  • Daniel Wilson

    Daniel Wilson, Executive Vice President, Corporate Development and Investor Relations

  • Karen Ling

    Karen Ling, Director

    • Dietra N. Jones

      Dietra N. Jones, Executive Vice President, Clinical Operations

    LocationsView all

    6 locations detected

    • San Francisco, CA HQ

      United States

      699 8th Street, Suite 600

    • Chicago, IL

      United States

      3 Parkway North, Suite 400

    • Cypress, CA

      United States

      6550 Katella Avenue, Suite 200

    • Houston, TX

      United States

      5775 North Sam Houston Parkway West, Suite 200

    • Mandaluyong, NCR

      Philippines

      Mega Tower 38th Floor Epifanio delos Santos Avenue (EDSA) corner Dona Julia Vargas St, Ortigas Center

    • London, England

      United Kingdom

      Seal House, 56 London Rd

    iRhythm Financials

    Summary Financials

    Revenue (Q1, 2024)
    $131.9M
    Gross profit (Q1, 2024)
    $87.5M
    Net income (Q1, 2024)
    ($45.7M)
    Cash (Q1, 2024)
    $520.4M
    EBIT (Q1, 2024)
    ($38.1M)
    Enterprise value
    $2.3B

    Footer menu